explain the roles of restriction endonucleases, DNA ligase, plasmids, DNA polymerase and reverse transcriptase in the transfer of a gene into an organism

Principles of Genetic Technology (Cambridge International AS & A Level – Topic 19)

Learning Objective

Explain the roles of restriction endonucleases, DNA ligase, plasmids, DNA polymerase and reverse transcriptase in the transfer of a gene into an organism, and describe the associated vectors, host cells, methods, screening techniques, applications and ethical considerations. (AO1 – knowledge; AO2 – understanding; AO3 – application)

1. Molecular Tools Used in Gene Transfer

1.1 Restriction Endonucleases (AO1, AO2)

  • Proteins that recognise short, specific DNA sequences (4–8 bp) and cleave the phosphodiester backbone.
  • Types of cuts:

    • Sticky (cohesive) ends – over‑hanging single‑stranded DNA that can base‑pair with a complementary sequence.
    • Blunt ends – straight cuts with no over‑hangs.

  • In recombinant DNA work they are used to cut both the vector and the gene of interest, creating compatible ends for ligation.

1.2 DNA Ligase (AO1, AO2)

  • Catalyses the formation of phosphodiester bonds between the 5′‑phosphate of one DNA fragment and the 3′‑hydroxyl of another.
  • Joins both sticky‑ended and blunt‑ended fragments (sticky ends ligate more efficiently).
  • Produces a stable recombinant DNA molecule ready for introduction into a host.

1.3 DNA Polymerases (AO1, AO2)

  • Thermostable Taq polymerase – high activity, low fidelity; ideal for routine PCR when sequence accuracy is not critical.
  • High‑fidelity polymerases (e.g., Pfu, Phusion) – possess proofreading activity; essential for cloning and downstream expression.
  • Roles in gene transfer:

    • Polymerase‑Chain Reaction (PCR) – amplifies the target gene to obtain sufficient quantity for cloning.
    • Repair of nicks – fills in missing nucleotides at sticky‑end junctions before ligase seals the backbone.

1.4 Reverse Transcriptase (AO1, AO2)

  • Synthesises complementary DNA (cDNA) from an RNA template.
  • Important for:

    • Converting eukaryotic mRNA (which may contain introns) into intron‑free cDNA suitable for expression in prokaryotic hosts.
    • Generating cDNA libraries for screening and cloning of specific genes.

2. Vectors for Gene Transfer (AO1, AO2)

Vector TypeTypical HostKey Features (exam‑relevant)
Plasmid (e.g., pUC, pBR322)Bacteria (E. coli)

  • Origin of replication (ori) – autonomous replication.
  • Selectable markers – ampicillin (AmpR), kanamycin (KanR), GFP.
  • Multiple cloning site (MCS) – many restriction sites.
  • Promoter – lac, T7 (inducible).

Viral vectors (retrovirus, adenovirus, lentivirus)Animal / mammalian cells

  • High transduction efficiency.
  • Retroviruses integrate into host genome; adenoviruses remain episomal.
  • Selectable markers – antibiotic resistance, fluorescent reporters.

Bacterial Artificial Chromosome (BAC)BacteriaCan carry inserts of 100–300 kb; useful for large genomic fragments.
Yeast Artificial Chromosome (YAC)Yeast (S. cerevisiae)Accommodates inserts up to 1 Mb; contains yeast centromere and telomeres.
Expression vectors (e.g., pET, pGEX)Bacteria, yeast, mammalian cells

  • Strong promoters (T7, CMV).
  • Affinity tags (His‑tag, GST) for protein purification.
  • Inducible systems (IPTG, arabinose).

3. Host Cells & Introduction Methods (AO1, AO2, AO3)

  • Bacterial hosts (E. coli)

    • Transformation by CaCl₂‑competent cells – heat‑shock (42 °C, 45 s) gives typical efficiencies of 10⁶ – 10⁸ cfu µg⁻¹ DNA.
    • Electroporation – brief high‑voltage pulse; efficiencies up to 10⁹ cfu µg⁻¹.

  • Yeast (S. cerevisiae)

    • Lithium acetate / PEG method – yields 10³ – 10⁴ transformants µg⁻¹.
    • Electroporation – higher efficiencies for large plasmids.

  • Plant cells

    • Agrobacterium‑mediated transformation – T‑DNA transfer; widely used for dicots.
    • Biolistic (gene‑gun) delivery – DNA‑coated gold/tungsten particles; suitable for monocots and cereal crops.

  • Mammalian cells

    • Calcium‑phosphate precipitation.
    • Liposome‑mediated delivery (lipofection).
    • Electroporation.
    • Viral vectors (see above).

4. Polymerase‑Chain Reaction (PCR) – Theory & Practice (AO1, AO2, AO3)

PCR is the cornerstone technique for obtaining large quantities of a specific DNA fragment.

4.1 Essential Components

  • Template DNA.
  • Two short primers (forward & reverse) – 18–25 nt, 40–60 % GC, Tm 50–65 °C, no significant secondary structures.
  • DNA polymerase (Taq for speed; high‑fidelity for cloning).
  • dNTPs, MgCl₂, buffer, and optional additives (e.g., DMSO for GC‑rich templates).

4.2 Cycle Stages

  1. Denaturation – 94–98 °C; separates strands.
  2. Annealing – 50–65 °C; primers bind to complementary sites.
  3. Extension – 72 °C; polymerase adds nucleotides (≈1 kb min⁻¹).

4.3 Practical Tips (AO2)

  • Mg²⁺ concentration influences enzyme activity and fidelity – usually 1.5–2.5 mM.
  • Number of cycles: 25–35 (each cycle doubles the product).
  • Use a “hot‑start” polymerase to reduce non‑specific amplification.
  • For cloning, include restriction sites in the 5′ ends of primers.

4.4 Quantitative PCR (qPCR) (AO2)

Real‑time monitoring using SYBR Green or TaqMan probes; provides quantitative data on gene expression.

4.5 Key Equation (placed with other equations)

Amount of DNA after n cycles:

\$N = N_0 \times 2^{n}\$

5. Screening & Confirmation of Recombinant Clones (AO1, AO2, AO3)

  • Blue‑white screening – lacZ α‑complementation; insertion of a gene disrupts β‑galactosidase, producing white colonies on X‑gal/IPTG plates.
  • Colony PCR – rapid test using primers flanking the MCS.
  • Restriction analysis – isolate plasmid, digest with diagnostic enzymes, compare band pattern on agarose gel.
  • DNA sequencing – definitive confirmation of insert identity and orientation.
  • Southern blotting – used for large constructs (BACs, YACs) to verify integration and copy number.
  • Phenotypic screening – antibiotic resistance, fluorescence (GFP), enzymatic colour change.

6. Step‑by‑Step Workflow for a Typical Gene‑Transfer Experiment (AO1‑AO3)

  1. Gene isolation – PCR amplification of the target gene or synthesis of cDNA using reverse transcriptase.
  2. Vector selection – choose a plasmid or other vector with appropriate promoter, selectable marker and MCS.
  3. Restriction digestion – cut both insert and vector with compatible enzymes (e.g., EcoRI + HindIII).
  4. Purification – gel‑extraction or column purification of the digested fragments.
  5. Ligation – mix insert and vector; allow sticky ends to anneal; add DNA ligase (typically 1 h at 16 °C).
  6. Transformation / Transfection

    • Bacterial transformation – heat‑shock or electroporation.
    • Yeast / plant transformation – lithium acetate or Agrobacterium.
    • Mammalian transfection – lipofection, calcium‑phosphate, or viral infection.

  7. Selection – plate on medium containing the appropriate antibiotic or screen for reporter activity.
  8. Screening – blue‑white screening, colony PCR, restriction analysis, or sequencing.
  9. Confirmation of expression – SDS‑PAGE, Western blot, enzyme assay, fluorescence microscopy, etc.

7. Real‑World Applications (AO1, AO2)

  • Recombinant insulin – human insulin gene cloned into a pBR322‑derived plasmid and expressed in E. coli.
  • Growth hormone (GH) – produced in bacterial or yeast expression systems for therapeutic use.
  • GM crops – Bt toxin gene in cotton/maize; glyphosate‑resistant wheat (EPSPS gene).
  • Gene therapy – AAV vectors delivering functional RPE65 for Leber congenital amaurosis.
  • Vaccines – recombinant hepatitis B surface antigen in yeast; mRNA vaccines (cDNA template generated by reverse transcription).
  • Genome editing – CRISPR/Cas9, TALENs and ZFNs used for knock‑in/out in plants, animals and human cells.

8. Ethical, Social and Environmental Issues (AO1)

  • Labelling of GM foods and consumer choice.
  • Potential impact of gene‑driven pest control on non‑target species.
  • Intellectual‑property rights versus access to life‑saving medicines.
  • Safety of gene‑therapy trials (off‑target effects, germ‑line modifications).
  • Bio‑security concerns surrounding the creation of novel pathogens.
  • Equity of benefit distribution between developed and developing nations.

9. Emerging Technologies Influencing Genetic Technology (AO1, AO2)

  • CRISPR/Cas9 – RNA‑guided nuclease for precise knock‑in, knock‑out and base editing.
  • TALENs & Zinc‑Finger Nucleases (ZFNs) – protein‑based DNA‑binding nucleases.
  • Synthetic biology – design of whole metabolic pathways (e.g., engineered microbes producing artemisinin).
  • RNA‑i and antisense technologies – post‑transcriptional gene silencing without altering DNA.
  • Prime editing – installs targeted insertions, deletions and all 12 possible base‑pair conversions without double‑strand breaks.

10. Summary Table – Molecular Tools and Their Primary Functions (AO1, AO2)

ToolPrimary FunctionKey Application in Gene Transfer
Restriction EndonucleasesSite‑specific DNA cleavageGenerate compatible ends on vector and insert.
DNA LigaseForm phosphodiester bondsJoin vector and insert to create recombinant DNA.
DNA Polymerase (Taq / high‑fidelity)DNA synthesis & repairPCR amplification of the gene; fill‑in of sticky ends; high‑fidelity synthesis for cloning.
Reverse TranscriptaseRNA → DNA synthesisProduce intron‑free cDNA for cloning; generate cDNA libraries.
Plasmids & Other VectorsAutonomous replication & gene carriageDeliver the gene into host cells; provide selection, promoters and replication origin.

11. Key Equations (AO2)

Amount of DNA after n PCR cycles:

\$N = N_0 \times 2^{n}\$

Ligation efficiency (probability of successful ligation of two sticky‑ended fragments):

\$P = 1 - e^{-k\,[\text{DNA}]\,t}\$

  • k = rate constant, [\text{DNA}] = concentration of DNA ends, t = incubation time.

12. Suggested Diagram (AO1)

Flowchart of the recombinant DNA process – from gene isolation (PCR or cDNA synthesis) → restriction digestion → ligation into a vector → transformation/transfection → selection → screening/confirmation → expression of the introduced gene.